We plan to record this event and make that recording available to all
registrants subsequently
If you can't make it on the day we encourage you to register anyway so
that you receive that link
AAG SECG & ERA present: Recent Aged Care Policy Reforms
and Research Implication
Update and Implications for Translational Research in Aged Care
Major government policy reforms to residential aged care have recently occurred in late 2023 with the transition from the Aged Care Funding Instrument to the Australian National Aged Care Classification model. Major changes include staffing, access to funding, and the expanded diversity of allied health professionals and treatments, to name a few.
Additionally, there is an ever-increasing push for translational research to produce more meaningful and practical treatments that directly benefit those living within aged care. However, designing and implementing these trials in aged care is difficult, and with amidst recent policy reforms it is vital that research design adapts to remain relevant.
This webinar will explore aged care policy changes and discuss implications for research design within these settings.
Attendees of this webinar will:
- Understand recent policy and funding changes to residential aged care
- Understand the challenges faced by aged care facilities following these changes
- Explore the role of translational research within these settings and challenges ahead
Hear from our speakers:
Leonie O’Neill
Registered Nurse and Director of Care
The Good Shepherd Home, Townsville, QLD
Leonie O’Neill is a Registered Nurse with over 30 years of experience including time as a clinical specialist, nurse unit manager, director of nursing and clinical governance lead at Mater Hospital in Townsville, QLD. In 2021, she made the transition from the hospital system to residential aged care and is now the Director of Care at The Good Shepherd Home, Townsville– a large, independent aged care facility situated in North Queensland. Leonie has steered the facility through the recent aged care reforms and is playing a pivotal role in the implementation of the FRIEND project, a translational trial currently taking place within the facility to improve frailty in residents through best practice treatments.
Dr Amy Page
Senior Research Fellow, Consultant Pharmacist, and Qualified Biostatistician
University of Western Australia
Dr Amy Page is a consultant pharmacist and biostatistician who is a NHMRC Early Career Fellow at the WA Centre for Health & Ageing.
Dr Page's research interests primarily relate to medicines safety and the quality use of medicines for older people, particularly those with dementia or chronic diseases or using polypharmacy. She has received over $3.5 million in research funding and published over 120 articles including more than 80 peer reviewed papers. She has presented on medicine safety and the quality use of medicines for older people nationally and internationally. Her research is frequently profiled in the professional and lay media. Dr Page has been consistently recognised by the Australian Journal of Pharmacy as one of the most influential people in pharmacy since 2017, most recently in December 2022. She was honoured to be named PSA’s 2015 Young Pharmacist of the Year, and received the 2022 Vice Chancellor's Early Career Researcher award.
Co-convened by:
Dr Michael Inskip
Lecturer, Clinical Educator and Accredited Exercise Physiologist
James Cook University, Townsville, QLD
Dr Michael Inskip is currently a lecturer, clinical educator, and early career researcher in exercise physiology at James Cook University, Townsville who has a passion for improving the assessment and provision of best practice care for those vulnerable older adults in the community and in aged care, including those with neurological conditions, frailty and dementia. He is an Accredited Exercise Physiologist with almost a decade of clinical and research trial experience and currently a co-investigator and exercise lead for the DCRC-funded Frailty Reduction via Implementation of Robust Exercise, Nutritional Support and Deprescribing (FRIEND) translational trial taking place in Townsville.
Dr Matthew Carroll
Senior Research Fellow at Monash University
National Convenor of the Emerging Researchers in Ageing
Dr Matthew Carroll is National Convenor of the Emerging Researchers in Ageing initiative and is a Senior Research Fellow at Monash University based in Churchill in Regional Victoria. Matthew is one of the lead investigators on the Hazelwood Health Study looking at the impacts of the 2014 Hazelwood mine fire, including the impacts on older people.